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Here, we provide the dataset associated with our research article
on the polyphosphate metabolism entitled, “Multi-level evaluation
of Escherichia coli polyphosphate related mutants using global
transcriptomic, proteomic and phenomic analyses”. By integrating
different omics levels (transcriptome, proteome and phenome), we
were able to study Escherichia coli polyphosphate mutant strains
(Δppk1, Δppx, and Δppk1-ppx). We have compiled here all datasets
from DNA microarrys, q-proteomic (Isotope-Coded Protein Label-
ing, ICPL) and phenomic (Phenotype microarray) raw data we have
obtained in all polyP metabolism mutants.
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.bbagen.2017.01.007
).
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Dubject area Biology
ore specific sub-
ject areaMicrobiologyype of data Tables and Figures
ow data was
acquiredFunctional genomic data were obtained using microarrays, Proteomic data were
obtained using Isotope Coded Protein Labeling (ICPL) and Phenomic data were
obtained using Biolog Phenotypic microarrayata format Raw and bioinformatic data
xperimental
factorsWe compare polyphosphate mutant strains (Δppk1, Δppx, and Δppk1-ppx) with
the wild typexperimental
featuresAll the strains were growth until mid-exponential phase and were analyzed as
described in Materials and Methodsata accessibility Microarray data are available at GEO: GSE29954, Q- proteomic raw.baf files
are available at http://goo.gl/NrKDCB
The rest of raw data is included in this article.Value of the data
 Three different omics approaches data are available that provides insights of the polyphosphate
metabolism in Escherichia coli.
 Functional genomics, quantitative proteomics and phenomics data are useful to identify novel
phenotypes and metabolic adjustments during alteration of polyP metabolism.
 This work contributes to the knowledge of bacterial polyphosphate metabolism and will help in
designing new and more effective antivirulence toward bacterial pathogens.1. Data
The data provided here represent different omics approaches to contribute to the understanding of
the metabolism of the polyphosphates in Escherichia coli. The raw data comprise information about
differential gene expression, protein abundance and response to different metabolites in three E. coli
mutants (Δppk1,Δppx, andΔpolyP) strains related to polyphosphate metabolism. This Data in Brief is
associated with the research article in BBA General Subjects entitled “Multi-level evaluation of
Escherichia coli polyphosphate related mutants using global transcriptomic, proteomic and phenomic
analyses” [1].2. Experimental design, materials and methods
Three mutant strains of E. coli lacking in the enzymes related to the polyphosphates metabolism
were generated (Δppk1, Δppx, and Δppk1-ppx). By different omics approaches (microarrays, quanti-
tative proteomic and phenotypic microarrays) we generated an overview of the metabolism of the
polyphosphates in this bacterium. The strains were growth in LB media until mid-exponential phase.
Total cells, RNA and proteins were extracted and delivered for their respective analysis. Comparisons
among the mutant strains and the wild type were performed at all omics levels.
2.1. Transcriptomics analysis using DNA microarray
E. coli 50-mer oligonucleotide library from MWGBiotech Oligo Sets (http://www.mwgbiotech.com)
were used for microarray analysis as previously described [1].
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(Packard BioChips). All images were captured using 65% PMT gain, 70–75% laser power and 10 mm
resolution at 50% scan rate.
Microarray data analysis was performed with free software genArise, developed in the Computing
Unit of Cellular Physiology Institute of UNAM (http://www.ifc.unam.mx/genarise/). GenArise carry out
a number of transformations: background correction, normalization, intensity filter, replicates ana-
lysis and selecting differentially expressed genes. The goal of genArise is to identify which genes show
good evidence of being differentially expressed. The software identifies differential expressed genes
by calculating an intensity-dependent z-score. Using a sliding window algorithm to calculate the
mean and standard deviation within a window surrounding each data point, and define a z-score
where z measures the number of standard deviations a data is from the mean.
zi¼(Ri–mean(R))/sd(R), where zi is the z-score for each element, Ri is the log-ratio for each ele-
ment, and sd(R) is the standard deviation of the log-ratio. With this criterion, the elements with a z-
score42 standard deviations would be the significantly differentially expressed genes.
The expression data were analyzed using the LIMMA framework in Bioconductor http://www.
bioconductor.org. Microarray data is available at the NCBI Gene Expression Omnibus (GEO) database
with the GSE29954 as accession number. Appendix file A contained raw files with all differentially
expressed genes (DEG).
2.2. Q-proteomics analysis using isotope-coded protein label (ICPL)
Total protein extracts preparation for ICPL analysis were prepared as previousy reported [2].
Proteome extracts from three biological replicates (different independent cultures) were mixed using
fifty micrograms of each one to obtain a triplicate representative sample of each experimental con-
dition with a total of 150 μg of protein in each case. Total protein was quantified using Bio-Rad Protein
Assay
s
(Bio-Rad, USA) and stored at 20 °C previous to the quantitative proteomics analysis.
ICPL-reagent protocol has been optimized for labeling 100 mg of each individual sample per
experiment. Thus, 100 mg of the wild-type and the mutant proteome were individually dissolved in
8 M Urea and 25 mM ammonium bicarbonate, reduced and alkylated with iodoacetamide. Urea
concentration was reduced to 2 M and sample digested with trypsin (ratio 20:1) O/N at 37 °C.
Digested samples were dried and resuspended in 50 ml of 0.2% trifluoroacetic acid in water and salts
and urea removed using high-capacity OMIX C18 tips (Varian, Palo Alto, Ca).
Labeling with the ICPL reagent was performed at the peptide level as previously described [1].
Briefly, 100 mg of each individual proteome sample was individually dissolved in 20 ml of lysis buffer
(containing 6 M of guanidinium chloride). ICPL reagent was added to each individual sample and
reaction was incubated at 25 °C for 2 h. Collective samples were dried in speed-vac and stored dry at
20 °C until needed. ICPL-labeled combined samples (200 mg per experiment) were fractionated by a
2D-LC approach. Second dimension of the 2D-nano LC ESI-MSMS analyses was performed using an
Ultimate 3000 nanoHPLC (Dionex, Sunnyvale, California) coupled to an HCT Ultra ion-trap mass
spectrometer (Bruker Daltonics, Bremen, Germany). The LC system was coupled via a nanospray
source (Bruker Daltonics, Bremen, Germany) to a 3D ion trap mass spectrometer operating in positive
ion mode with the capillary voltage set at 1400 V. Automatic data-dependent acquisition allowed to
obtain sequentially both full scan (m/z 350–1500) MS spectra followed by tandem MS CID spectra of
the four most abundant ions. Dynamic exclusion was applied to prevent the same m/z from being
isolated for 1 min after its fragmentation.
MS and MS/MS data obtained for individual HPLC fractions were merged using the Analysis
Combiner tool and subsequently processed as a single experiment. Merged raw MS and MSMS data
were processed using DataAnalysis 3.4 (Bruker Daltonics, Bremen, Germany). For protein identifica-
tion, the Escherichia coli strain K12 database, containing 4407 protein coding genes, was downloaded
from the UniProtKB Protein Knowledgebase (http://www.uniprot.org/) [3]. Original.baf files (Bruker
Daltonics) for all three mutants are available upon request or available at site http://goo.gl/NrKDCB.
A combined database containing both forward and their corresponding reversed sequences was
generated using the program pSCAN (http://pfind.ict.ac.cn). MSMS spectra (in the form of mascot
generic files) were searched against this combined database using a licensed version of Mascot
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lows: carbamidomethyl cystein as fixed modification, oxidized methionines and ICPL- labeling of
lysine residues and/or peptide amino termini as variable ones. Peptide mass tolerance was set at
0.6 Da both in MS and MS/MS mode, and 1 missed cleavage was allowed. Typically, an accuracy of
70.1–0.2 Da was found both for MS and MS/MS spectra. False Discovery Rates (FDR r5%) for peptide
identification was manually calculated as follows: after database searching, peptide matches with a
Mascot score 420 were ordered according to their Mascot scores.
Appendix file B contained the raw datasets with the list contained peptide sequences matching
either forward or reversed database sequences. Then, a sublist containing only a 5% of peptides
matching the reversed sequences was extracted and used for further analysis. Quantitative analysis
was performed using WARP-LC 1.1 (Bruker Daltonics) using the parameters described above. When
only one ICPL-labeled peptide was identified, the extracted ion chromatogram of its putative partner
was used for quantification. Putative ICPL pairs were determined allowing a mass tolerance of 0.5 Da
and a retention time tolerance of 40 s. Relative ratios between the light and heavy counterparts of
ICPL-labeled peptides were calculated using the intensity of their respective monoisotopic peaks.
Except where indicated otherwise, only proteins identified and quantified with at least two peptides
were considered. Ratios were log2-transformed and normalized by subtracting the median value.2.3. Phenomic analysis using phenotypic microarrays
Bacterial cell suspensions from E. coli polyphosphate metabolism mutant strains were inoculated
into each of the 20 PM plates for full metabolic profiling according to standard protocols recom-
mended by Biolog Inc [4]. E. coli K12 was used as parental control strains in all experiments. The PM
plates (complete set) were located in an aerobic OmniLog incubator reader set at 30 °C which col-
lected data every 15 min over a 72-h period. PM tests were conducted in duplicate, and the plates
were also examined visually at the end of each incubation period for independent confirmation. The
OmniLog
s
V. 1.5 comparison module and the average height parameter were used for data analysis
with standard thresholds for detection. A consensus graphical profiles for all metabolic and sensitivity
tests for each mutant were generated using two independent runs as previously reported [5]. Original
raw data from all polyP mutants strains is available for each polyP metabolism mutant in Appendix
file C.Acknowledgments
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